Summary
The current ‘genomics’ era is an exciting time for drug target discovery with considerable opportunities for therapeutic intervention. Whilst classical small molecules remain the reagents of choice as chemical probes for target validation, not all targets are tractable...
More information & hyperlinks
Web resources: | https://kawamuraresearchgroup.com |